Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro KwikPen — including the 2.5mg and 5mg doses most associated with the so-called "golden dose" — delivers 0.5ml per injection. That volume is fixed regardless of strength; the concentration of tirzepatide in that 0.5ml changes as you move up the dosing schedule, not the amount of liquid itself. Mounjaro is a prescription-only medicine, so a GPhC-registered prescriber decides which strength is right for you based on a full clinical assessment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro comes as a pre-filled, auto-injecting KwikPen. You press it against the skin, press the button, and the pen delivers 0.5ml. That is true whether you are on the 2.5mg starter pen or the 15mg maintenance pen. The number on the pen label refers to the amount of tirzepatide in that 0.5ml, not the volume of the injection itself. A 2.5mg pen contains 5mg of tirzepatide per ml; a 15mg pen contains 30mg per ml. Same syringe-fill volume, very different concentrations.
This distinction matters if you have come across references to "0.5ml" on forums or social media. Some people draw the (incorrect) conclusion that you could measure out a different volume to alter their dose. You cannot, and you should not try. The KwikPen is factory-set. Any attempt to draw the solution into a separate syringe would be outside the licensed instructions and potentially unsafe.
For the mechanics of how to hold, position and activate the pen, our guide to taking the golden dose Mounjaro walks through each step using the instructions from the licensed leaflet.
"Golden dose" is not a term you will find in the NHS tirzepatide patient guidance or in any clinical trial report. It emerged online (largely via patient communities) to describe the point in the titration schedule where the side-effect burden tends to lighten and appetite suppression becomes clearly noticeable. Most people use it to mean the 5mg dose, though some apply it to 2.5mg, and you can read more about what the golden dose looks like at the 2.5mg starting stage if that is where you currently are.
The licensed schedule starts at 2.5mg for the first four weeks, primarily to give your digestive system time to adjust. After that, the prescriber typically moves the dose to 5mg, and upward in four-week steps from there. The 2.5mg pen exists for tolerability, not as a therapeutic target; the clinical evidence (including the SURMOUNT-1 trial published in the New England Journal of Medicine) was built on the higher maintenance doses. Whether your personal "golden" point is 5mg or somewhere higher is something only your own body and your prescriber can establish over time.
If you want a closer look at what distinguishes the 5mg experience specifically, there is a separate page covering the 5mg golden dose in more detail.
Because every injection is 0.5ml and the pen is pre-set, your handling routine is straightforward. The pen lives in the fridge between uses (stored at 2–8°C) and each cartridge gives four weekly doses before it is spent. After the final dose, dispose of it in a yellow sharps container rather than household waste.
One practical note: if your pen is due mid-holiday or just before a bank holiday, plan ahead so you are not left waiting on a delivery. Ordering before the 12pm cut-off on a working day means same-day dispatch once a prescriber has reviewed your case, with next-working-day arrival, but non-working days do not count.
For anything specific about room-temperature windows or what to do if a dose is delayed, the manufacturer's Patient Information Leaflet (available on the Electronic Medicines Compendium) is the definitive reference. Prescribers and aftercare teams can also advise; details are on the contact page.
The volume per injection is 0.5ml. Now that is answered, the more useful question is whether the dose you are on (or considering) is the right one for you, and our overview of the Mounjaro golden dose is a good place to explore that further before speaking to a prescriber. That is a clinical call. NICE's appraisal of tirzepatide (TA1026) sets out the clinical criteria under which it is recommended, and private eligibility broadly mirrors the licensed indications: adults with a BMI of 30 or above, or 27 and above alongside a weight-related health condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK guidance.
A prescriber's job is to match dose and schedule to your health picture, not to follow a forum's definition of the golden dose. If you are weighing up whether tirzepatide is the right route and want a clinical view rather than another search, you can explore our treatment options or read more about how the broader Mounjaro treatment works at nume. Every consultation at nume is reviewed by a GPhC-registered Independent Prescriber (a real clinician, not an automated system) and there is no charge for the assessment itself.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.